Mumbai: Jagsonpal Pharmaceuticals announced the acquisition of India And Bhutan Businesses of Yash PharmaThe transaction was facilitated by a boutique investment banking firm Growthly AdvisorsIt is expected that this will not only expand Jagsonpal’s therapeutic reach but also improve its market ranking.

This acquisition is also significant as it is two companies that complement each other and are merging with each other. Jagsonpal has already built a 60-year legacy with its strong presence in gynecology and orthopedics. This has now grown even further as Yash Pharma’s well-established portfolio of 33 dermatology and pediatric brands becomes part of their offering. This strategic move not only diversifies Jagsonpal’s product offerings, but it also allows them to establish their presence in a new market segment worth ₹20,000 crore (Source: IQVIA), which offers significant growth opportunities.

As a Jagsonpal spokesperson said, “This acquisition is the perfect recipe for Jagsonpal. Yash Pharma’s strengths in dermatology and pediatrics can now be leveraged to align with our long-term growth objectives. Now, with the expansion of our portfolio with this access to new customer segments, the company is poised to significantly strengthen its market position.”
Bhupinder GargManaging Director (MD) of Growthly Advisors said, “We are proud to be the architects of this mutually beneficial partnership. We believe this transaction is a perfect example of how strategic acquisitions can ensure benefits for all stakeholders.” Garg added, “Indian Pharmaceutical field In particular, there will be growth at a significant rate. Strategically planned Collaboration And acquisitions will be the key driving force towards unlocking the huge potential of this industry.”

This exclusive acquisition puts Jagsonpal in a strong position to continue its growth and innovation journey. They are expected to further strengthen their market presence by leveraging this expanded portfolio. The operational synergy with Yash Pharma is also expected to enhance profitability for both companies, empowering them to deliver greater value to their customers and stakeholders.